Proposal of New Prognostic Index for Patients with Diffuse Large B-Cell Lymphoma in the Rituximab Era

被引：0
|
作者：
Yoon, Shinkyo [1 ]
Yoon, Dok Hyun [1 ]
Kim, Shin [2 ]
Lee, Kyoungmin [2 ]
Kang, Eun Hee [2 ]
Lee, Sang-wook [3 ]
Park, Chan-Jeoung [4 ]
Park, Chan-Sik [5 ]
Huh, Jooryung [5 ]
Suh, Cheolwon [2 ]
机构：
[1] Asan Med Ctr, Seoul, South Korea
[2] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South Korea
[3] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiat Oncol, Seoul, South Korea
[4] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Lab Med, Seoul, South Korea
[5] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pathol, Seoul, South Korea
来源：
BLOOD | 2014年 / 124卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [41] The Enhanced International Prognostic Index for Diffuse Large B-cell Lymphoma
    Yang, Yan
    Wang, Lanlan
    Ma, Yanna
    Han, Tingting
    Huang, Mei
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2017, 353 (05): : 459 - 465
  • [42] Excellent outcomes and lack of prognostic impact of cell of origin for localized diffuse large B-cell lymphoma in the rituximab era
    Kumar, Anita
    Lunning, Matthew A.
    Zhang, Zhigang
    Migliacci, Jocelyn C.
    Moskowitz, Craig H.
    Zelenetz, Andrew D.
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 171 (05) : 776 - 783
  • [43] A Clinico-Genotypic Prognostic Index for De Novo Composite Diffuse Large B-Cell Lymphoma Arising from Follicular Lymphoma in the Rituximab Era
    Lim, Ryan Mao Heng
    Chan, Natalie Pei Xin
    Khoo, Lay Poh
    Cheng, Chee Leong
    Tan, Leonard
    Yi, Eileen
    Poon, Ling
    Somasundaram, Nagavalli
    Farid, Mohamad
    Tang, Tiffany
    Tao, Miriam
    Lim, Soon Thye
    Chan, Jason Yongsheng
    BLOOD, 2018, 132
  • [44] The Prognostic Impact of Absolute Lymphocyte and Monocyte Counts at Diagnosis of Diffuse Large B-Cell Lymphoma in the Rituximab Era
    Aoki, Kazunari
    Tabata, Sumie
    Yonetani, Noboru
    Matsushita, Akiko
    Ishikawa, Takayuki
    ACTA HAEMATOLOGICA, 2013, 130 (04) : 242 - 246
  • [45] Rituximab and CHOP for elderly patients with diffuse large B-cell lymphoma
    Carol S. Portlock
    Current Oncology Reports, 2003, 5 (5) : 357 - 357
  • [46] Rituximab and chemotherapy in diffuse large B-cell lymphoma
    Sonet, Anne
    Bosly, Andre
    EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (06) : 719 - 726
  • [47] Role of consolidative radiation therapy for patients with mediastinal diffuse large B-cell lymphoma in the rituximab era
    Sert, Fatma
    Kamer, Serra
    Saydam, Guray
    Anacak, Yavuz
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2018, 14 (06) : 1397 - 1402
  • [48] The rationale and role of radiation therapy in the treatment of patients with diffuse large B-cell lymphoma in the Rituximab era
    Wirth, Andrew
    LEUKEMIA & LYMPHOMA, 2007, 48 (11) : 2121 - 2136
  • [49] Benefit of Consolidative Radiotherapy in Patients with Limited Stage Diffuse Large B-Cell Lymphoma in the Rituximab Era
    Nakamura, Nobuhiko
    Ikoma, Yoshikazu
    Shibata, Yuhei
    Matsumoto, Takuro
    Ninomiya, Soranobu
    Kitagawa, Junichi
    Shimizu, Masahito
    Hara, Takeshi
    Tsurumi, Hisashi
    BLOOD, 2016, 128 (22)
  • [50] The role of radiotherapy for patients over age 60 with diffuse large B-cell lymphoma in the rituximab era
    Cassidy, R. J.
    Jegadeesh, N.
    Switchenko, J.
    Danish, H.
    Esiashvili, N.
    Flowers, C. R.
    Khan, M. K.
    LEUKEMIA & LYMPHOMA, 2016, 57 (08) : 1876 - 1882
12345